Template:Travelers Diarrhea Antibiotics - Revision history

Danbot: Convert to AntibioticDose with disease=Traveler's diarrhea

2026-03-19T23:32:20Z

Convert to AntibioticDose with disease=Traveler's diarrhea

← Older revision		Revision as of 23:32, 19 March 2026
Line 1:		Line 1:
	*[[Ciprofloxacin]] 750mg PO once daily x 1-3 days<ref>Hoge CW. et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26:341–5</ref>		*{{AntibioticDose\|disease=Traveler's diarrhea\|drug=Ciprofloxacin\|dose=750mg PO once daily x 1-3 days\|context=Traveler's Diarrhea}}<ref>Hoge CW. et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26:341–5</ref>
	**First choice for use except in South and Southeast Asia<ref>Steffen R, et al. ~~Traveler’s~~ Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006</ref>		**First choice for use except in South and Southeast Asia<ref>Steffen R, et al. Traveler's Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006</ref>
	*[[Azithromycin]] 500mg PO q24h x 3 days OR 1000mg PO x 1<ref>Sanders JW. et al. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. Am J Trop Med Hyg. 2002;67:533–8</ref>		*{{AntibioticDose\|disease=Traveler's diarrhea\|drug=Azithromycin\|dose=500mg PO q24h x 3 days OR 1000mg PO x 1\|context=Traveler's Diarrhea}}<ref>Sanders JW. et al. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. Am J Trop Med Hyg. 2002;67:533–8</ref>
	**Nausea is a frequent adverse event<ref>Steffen R, et al. ~~Traveler’s~~ Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006</ref>		**Nausea is a frequent adverse event<ref>Steffen R, et al. Traveler's Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006</ref>
	**First choice for use in South and Southeast Asia<ref>Steffen R, et al. ~~Traveler’s~~ Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006</ref>		**First choice for use in South and Southeast Asia<ref>Steffen R, et al. Traveler's Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006</ref>
	*[[Rifaximin]] 200mg PO TID x 3 days<ref>DuPont HL. et al. Rifaximin versus ciprofloxacin for the treatment of ~~traveler’s~~ diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis. 2001;33:1807–15</ref>		*{{AntibioticDose\|disease=Traveler's diarrhea\|drug=Rifaximin\|dose=200mg PO TID x 3 days\|context=Traveler's Diarrhea}}<ref>DuPont HL. et al. Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis. 2001;33:1807–15</ref>
	**Ineffective against mucosally invasive pathogens ([[Shigella]], [[Salmonella]], [[Campylobacter]])		**Ineffective against mucosally invasive pathogens ([[Shigella]], [[Salmonella]], [[Campylobacter]])
	**Considered very safe as it is not absorbed		**Considered very safe as it is not absorbed

Rossdonaldson1 at 23:36, 6 January 2015

2015-01-06T23:36:09Z

← Older revision		Revision as of 23:36, 6 January 2015
Line 1:		Line 1:
	*[[Ciprofloxacin]] 750mg PO once daily x 1-3 days<ref>Hoge CW. et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26:341–5</ref>		*[[Ciprofloxacin]] 750mg PO once daily x 1-3 days<ref>Hoge CW. et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26:341–5</ref>
	**First choice for use except in South and Southeast Asia		**First choice for use except in South and Southeast Asia<ref>Steffen R, et al. Traveler’s Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006</ref>
	*[[Azithromycin]] 500mg PO q24h x 3 days OR 1000mg PO x 1<ref>Sanders JW. et al. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. Am J Trop Med Hyg. 2002;67:533–8</ref>		*[[Azithromycin]] 500mg PO q24h x 3 days OR 1000mg PO x 1<ref>Sanders JW. et al. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. Am J Trop Med Hyg. 2002;67:533–8</ref>
	**Nausea is a frequent adverse event		**Nausea is a frequent adverse event<ref>Steffen R, et al. Traveler’s Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006</ref>
	**First choice for use in South and Southeast Asia		**First choice for use in South and Southeast Asia<ref>Steffen R, et al. Traveler’s Diarrhea: A Clinical Review. JAMA. 2015;313(1):71-80. doi:10.1001/jama.2014.17006</ref>
	*[[Rifaximin]] 200mg PO TID x 3 days<ref>DuPont HL. et al. Rifaximin versus ciprofloxacin for the treatment of traveler’s diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis. 2001;33:1807–15</ref>		*[[Rifaximin]] 200mg PO TID x 3 days<ref>DuPont HL. et al. Rifaximin versus ciprofloxacin for the treatment of traveler’s diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis. 2001;33:1807–15</ref>
	**Ineffective against mucosally invasive pathogens ([[Shigella]], [[Salmonella]], [[Campylobacter]])		**Ineffective against mucosally invasive pathogens ([[Shigella]], [[Salmonella]], [[Campylobacter]])
	**Considered very safe as it is not absorbed		**Considered very safe as it is not absorbed

Rossdonaldson1 at 21:53, 6 January 2015

2015-01-06T21:53:10Z

← Older revision		Revision as of 21:53, 6 January 2015
Line 1:		Line 1:
	*[[Ciprofloxacin]] 750mg PO ~~BID~~ x 1-3 days<ref>Hoge CW. et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26:341–5</ref>		*[[Ciprofloxacin]] 750mg PO once daily x 1-3 days<ref>Hoge CW. et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26:341–5</ref>
	*[[~~Levofloxacin~~]] 500mg PO q24h x 1-~~3 days~~		**First choice for use except in South and Southeast Asia
	*~~[[Ofloxacin]] 300mg PO BID x 3 days~~		*[[Azithromycin]] 500mg PO q24h x 3 days OR 1000mg PO x 1<ref>Sanders JW. et al. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. Am J Trop Med Hyg. 2002;67:533–8</ref>
			**Nausea is a frequent adverse event
			**First choice for use in South and Southeast Asia
	*[[Rifaximin]] 200mg PO TID x 3 days<ref>DuPont HL. et al. Rifaximin versus ciprofloxacin for the treatment of traveler’s diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis. 2001;33:1807–15</ref>		*[[Rifaximin]] 200mg PO TID x 3 days<ref>DuPont HL. et al. Rifaximin versus ciprofloxacin for the treatment of traveler’s diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis. 2001;33:1807–15</ref>
	*[[~~Azithromycin~~]] 1000mg PO x 1 OR 500mg PO q24h x 3 days<ref>Sanders JW. et al. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter ~~infection. Am J Trop Med Hyg. 2002;67:533–8</ref>~~		**Ineffective against mucosally invasive pathogens ([[Shigella]], [[Salmonella]], [[Campylobacter]])
			**Considered very safe as it is not absorbed

Ostermayer: Created page with "*Ciprofloxacin 750mg PO BID x 1-3 daysHoge CW. et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1..."

2014-09-02T21:39:05Z

Created page with "*Ciprofloxacin 750mg PO BID x 1-3 days<ref>Hoge CW. et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1..."

New page

*[[Ciprofloxacin]] 750mg PO BID x 1-3 days<ref>Hoge CW. et al. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis. 1998;26:341–5</ref>
*[[Levofloxacin]] 500mg PO q24h x 1-3 days
*[[Ofloxacin]] 300mg PO BID x 3 days
*[[Rifaximin]] 200mg PO TID x 3 days<ref>DuPont HL. et al. Rifaximin versus ciprofloxacin for the treatment of traveler’s diarrhea: a randomized, double-blind clinical trial. Clin Infect Dis. 2001;33:1807–15</ref>
*[[Azithromycin]] 1000mg PO x 1 OR 500mg PO q24h x 3 days<ref>Sanders JW. et al. An observational clinic-based study of diarrheal illness in deployed United States military personnel in Thailand: presentation and outcome of Campylobacter infection. Am J Trop Med Hyg. 2002;67:533–8</ref>